Cargando…

Surveillance of cirrhosis for hepatocellular carcinoma: a cost–utility analysis

Using a decision-analytic model, we evaluated the effectiveness and cost-effectiveness of surveillance for hepatocellular carcinoma (HCC) in individuals with cirrhosis. Separate cohorts with cirrhosis due to alcoholic liver disease, hepatitis B and hepatitis C were simulated. Results were also combi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Thompson Coon, J, Rogers, G, Hewson, P, Wright, D, Anderson, R, Jackson, S, Ryder, S, Cramp, M, Stein, K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2008
Materias:	Clinical Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2359641/ https://www.ncbi.nlm.nih.gov/pubmed/18382459 http://dx.doi.org/10.1038/sj.bjc.6604301

Ejemplares similares

A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis
por: Biselli, M, et al.
Publicado: (2015)

Prognostic factors and treatment effects for hepatocellular carcinoma in Child C cirrhosis
por: Nouso, K, et al.
Publicado: (2008)

Sunitinib and bevacizumab for first-line treatment of metastatic renal cell carcinoma: a systematic review and indirect comparison of clinical effectiveness
por: Thompson Coon, J S, et al.
Publicado: (2009)

Portal vein thrombosis in patients with hepatocellular carcinoma and early cirrhosis—prevalence and risk factors
por: Siddiqui, Muhammad Tayyab Ul-Hasan, et al.
Publicado: (2023)

The utility and cost of routine follow-up procedures in the surveillance of ovarian and primary peritoneal carcinoma: a 16-year institutional review
por: Rettenmaier, N B, et al.
Publicado: (2010)

Sorafenib Prevents Escape from Host Immunity in Liver Cirrhosis Patients with Advanced Hepatocellular Carcinoma
por: Nagai, Hidenari, et al.
Publicado: (2012)

A Phase-1b study of tivantinib (ARQ 197) in adult patients with hepatocellular carcinoma and cirrhosis
por: Santoro, A, et al.
Publicado: (2013)

Impact of disease stage and aetiology on survival in hepatocellular carcinoma: implications for surveillance
por: Johnson, Philip, et al.
Publicado: (2017)

Outcomes of curative liver resection for hepatocellular carcinoma in patients with cirrhosis
por: Elshaarawy, Omar, et al.
Publicado: (2021)

Surveillance for Hepatocellular Carcinoma after Autologous Stem Cell Transplantation in Cirrhosis
por: Mohamadnejad, Mehdi, et al.
Publicado: (2012)

Management of Esophageal Carcinoma Associated with Cirrhosis: A Retrospective Case-Control Analysis
por: Trivin, Florence, et al.
Publicado: (2009)

Polymorphisms of folate metabolism genes in patients with cirrhosis and hepatocellular carcinoma
por: Peres, Nathália Perpétua, et al.
Publicado: (2016)

Hepatocellular carcinoma with child Pugh-A Cirrhosis treated with stereotactic body radiotherapy
por: Hasan, Shaakir, et al.
Publicado: (2017)

Prostate-specific membrane antigen expression in hepatocellular carcinoma, cholangiocarcinoma, and liver cirrhosis
por: Chen, Li-Xing, et al.
Publicado: (2020)

Acute kidney injury after multiphase imaging for lesions detected on hepatocellular carcinoma surveillance in patients with cirrhosis
por: Khan, Adnan Aman, et al.
Publicado: (2020)

Immunohistochemical angiogenic biomarkers in hepatocellular carcinoma and cirrhosis: correlation with pathological features
por: Ribeiro, Osmar Damasceno, et al.
Publicado: (2016)

Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
por: Ganne-Carrié, Nathalie, et al.
Publicado: (2021)

Contrast-enhanced US with Perfluorobutane(Sonazoid) used as a surveillance test for Hepatocellular Carcinoma (HCC) in Cirrhosis (SCAN): an exploratory cross-sectional study for a diagnostic trial
por: Park, Ji Hoon, et al.
Publicado: (2017)

Comparison of Staging Systems of Hepatocellular Carcinoma
por: Sirivatanauksorn, Yongyut, et al.
Publicado: (2011)

Angiogenic Factor Expression in Hepatic Cirrhosis
por: Giatromanolaki, Alexandra, et al.
Publicado: (2007)

Risk of Liver Cirrhosis and Hepatocellular Carcinoma after Fontan Operation: A Need for Surveillance
por: Yoon, Jun Sik, et al.
Publicado: (2020)

Comparison of biannual ultrasonography and annual non-contrast liver magnetic resonance imaging as surveillance tools for hepatocellular carcinoma in patients with liver cirrhosis (MAGNUS-HCC): a study protocol
por: Kim, Hyun A, et al.
Publicado: (2017)

Incidence of hepatocellular carcinoma in outpatients with cirrhosis in Brazil: A 10-year retrospective cohort study
por: Appel-da-Silva, Marcelo Campos, et al.
Publicado: (2016)

Clinical significance of half-hepatic blood flow occlusion technology in patients with hepatocellular carcinoma with cirrhosis
por: Liu, Dong, et al.
Publicado: (2022)

Multidisciplinary Management of Hepatocellular Carcinoma in Clinical Practice
por: Bruera, Gemma, et al.
Publicado: (2014)

Epidemiology and Prognosis of Paraneoplastic Syndromes in Hepatocellular Carcinoma
por: Chang, Pik Eu, et al.
Publicado: (2013)

Cost-Effectiveness of Risk Score–Stratified Hepatocellular Carcinoma Screening in Patients with Cirrhosis
por: Goossens, Nicolas, et al.
Publicado: (2017)

Diastolic Dysfunction and Severity of Cirrhosis in Nonalcoholic Cirrhotic Patients
por: Salari, A., et al.
Publicado: (2013)

Cost-utility of stereotactic radiation therapy versus proton beam therapy for inoperable advanced hepatocellular carcinoma
por: Leung, Henry W.C., et al.
Publicado: (2017)

Individual surveillance by competing risk model for patients with hepatocellular carcinoma occurrence in all-cause cirrhosis
por: Wang, Qi, et al.
Publicado: (2023)

MicroRNA-429 Modulates Hepatocellular Carcinoma Prognosis and Tumorigenesis
por: Huang, Xiao-Ying, et al.
Publicado: (2013)

Metabolic Bone Disease in Viral Cirrhosis: A Prospective Study
por: Goubraim, Rabia, et al.
Publicado: (2013)

Type 2 diabetes mellitus characteristics affect hepatocellular carcinoma development in chronic hepatitis B patients with cirrhosis
por: Li, Man-Yu, et al.
Publicado: (2023)

Preoperative Gadoxetic Acid-Enhanced MRI and Simultaneous Treatment of Early Hepatocellular Carcinoma Prolonged Recurrence-Free Survival of Progressed Hepatocellular Carcinoma Patients after Hepatic Resection
por: Matsuda, Masanori, et al.
Publicado: (2014)

Outcomes of National Survey of the Practice of Hepatocellular Carcinoma Surveillance
por: Scott, Robert A, et al.
Publicado: (2023)

Hyponatremia in Hepatocellular Carcinoma Complicating with Cirrhosis
por: Nishikawa, Hiroki, et al.
Publicado: (2015)

Prognostic indicators in hepatocellular carcinoma: a systematic review of 72 studies
por: Tandon, Puneeta, et al.
Publicado: (2009)

Clinical Characteristics and Surgical Prognosis of Hepatocellular Carcinoma with Bile Duct Invasion
por: Meng, Ke-Wei, et al.
Publicado: (2014)

Pro-angiogenic cytokines for prediction of outcomes in patients with advanced hepatocellular carcinoma
por: Miyahara, K, et al.
Publicado: (2013)

Sorafenib for advanced hepatocellular carcinoma (HCC): impact of rationing in the United Kingdom
por: Palmer, D H, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_s6sujr2l7o2pa63c9v61bgu3a5